7When the Tumour Is Not the Problem: The Non-Tumour ABI
In adults whose cochlea or cochlear nerve has failed but whose brainstem is intact, the auditory brainstem implant performs far better than it does after vestibular schwannoma surgery, sometimes approaching cochlear implant levels.
FThe candidate who is not a CI candidate
A cochlear implant only works if there is a cochlea to enter and a cochlear nerve to carry the signal onward. Some profoundly deaf adults have neither in usable form: the cochlea may be completely ossified after bacterial meningitis or advanced otosclerosis, the cochlear nerve may have been avulsed in a transverse temporal bone fracture, or it may be congenitally aplastic behind a stenotic internal auditory canal. For these patients an electrode in the scala tympani has nothing to stimulate.
The auditory brainstem implant solves the problem by skipping the failed periphery altogether. Its paddle of surface electrodes sits on the cochlear nucleus, the first relay station inside the brainstem, and stimulates the second-order auditory neurons directly. Originally built for people left deaf by neurofibromatosis type 2 surgery, the device was extended from the late 1990s to adults with non-tumour cochlear and nerve disease who would otherwise have no hearing option at all.[2005][2019]
TWhy a healthy brainstem changes everything
The striking clinical observation is that non-tumour ABI users hear better than NF2 users with the identical device on the identical target. In pooled European data, open-set sound-only sentence scores in non-tumour adults ranged widely but averaged around 59 percent, while matched NF2 users averaged only about 10 percent. A few non-tumour users reach scores indistinguishable from good cochlear implant performance.
Psychophysical comparison of tumour and non-tumour users showed that both groups have adequate surviving neurons and similar electrode placement, yet NF2 users have markedly poorer amplitude-modulation detection and speech understanding. The leading explanation is that the tumour itself, or its removal, damages the cochlear nucleus by compression, by devascularisation, or by disrupting a specialised neuronal subpopulation needed for temporal processing. In the non-tumour patient the nucleus and its blood supply are pristine, so the same surface array drives a healthier substrate.
Aetiology therefore predicts outcome. Adults deafened by head trauma with cochlear nerve damage, or by cochlear ossification, tend to do best and keep improving for years; those with auditory neuropathy or cochlear malformation receive useful but more modest benefit, because their lesion may extend into the central pathway.[2005][2004][2014]
CSelecting and counselling the non-tumour adult
The non-tumour candidate differs from the NF2 candidate in a crucial way: there is no tumour forcing the operation. The person is choosing a posterior fossa craniotomy purely to gain sound, so the risk-benefit conversation must be explicit. CSF leak, meningitis, lower-cranial-nerve injury and, rarely, brainstem stroke are weighed against a realistic ceiling of benefit that ranges from environmental sound and lip-reading support to, in favourable aetiologies, open-set speech.
Workup confirms that the cochlea or nerve genuinely cannot be implanted with a CI, usually with high-resolution CT and MRI showing the ossified or absent cochlea, the avulsed or aplastic nerve, or a narrow internal auditory canal. Where doubt exists, many surgeons still attempt or trial a cochlear implant first, reserving the ABI as a salvage option for the patient who derives no useful perception from the CI.[2004][2002][2019]
CWhat the non-tumour adult can expect to hear
Counselling should set expectations along a ladder of difficulty: sound detection first, then pattern and rhythm perception, then closed-set and finally, for some, open-set word recognition. Even users who never reach open-set speech alone usually gain substantial improvement when ABI sound is combined with lip-reading, and report that environmental sound awareness improves safety and quality of life.
Improvement is slow and continues for years as the user and the programming audiologist learn the device, so the postoperative commitment to rehabilitation is as important as the surgery itself. The best single predictor a clinician can offer the patient is the cause of their deafness: a clean traumatic or post-meningitic ossification picture carries the most optimistic prognosis, while a malformation or neuropathy carries a more guarded one.[2005][2014]
What is the most appropriate next step?
Why do non-tumour ABI users generally outperform NF2 ABI users with the same device?
Which non-tumour aetiology tends to give the BEST ABI speech outcome?
An adult with bilateral cochlear ossification gets only non-auditory twitching and inconsistent detection from a cochlear implant. The ABI is best described here as:
Which risk must be discussed specifically because the non-tumour adult is operating purely to gain sound?
What is the single most useful predictor of likely ABI benefit a clinician can give a non-tumour candidate preoperatively?